27/06/2025 - General information
Dr. Alicia Prieto, researcher at the Heart Disease Research Group of the Hospital del Mar Research Institute of Barcelona (HMRIB) and cardiologist at Hospital del Mar, has been awarded one of the three Daniel Bravo Foundation Fellowships to carry out advanced research in cardiology at leading international centers, including the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ).
20/06/2025 - Press release
People with Chronic Obstructive Pulmonary Disease (COPD) who suffer from sarcopenia, or loss of muscle capacity, have higher levels of a protein called myostatin, which, under normal conditions, helps regulate muscle growth. Elevated levels of this protein trigger a series of reactions in the muscle cells, preventing regeneration and growth after damage, leading to muscle mass loss in these patients. This was revealed by a study from the Hospital del Mar and the Hospital del Mar Research Institute, which opens the door to developing treatments targeted at this protein to reverse this situation.
Més informació "Researchers Discover the Cause of Muscle Loss in Some COPD Patients"
20/05/2025 - Press release
A study from the Hospital del Mar, the Hospital del Mar Research Institute, and the Reference Laboratory of Catalonia validates the effectiveness of combining a molecule, apotransferrin, with existing antibiotics to treat the antibiotic-resistant bacteria Pseudomonas aeruginosa. The research, published in the International Journal of Antimicrobial Agents, opens the door to a new strategy for tackling the problem of antibiotic-resistant bacteria by preventing them from accessing the iron they need to complete their life cycle. The new drug combination enhances the ability of antibiotics. Additionally, apotransferrin is a drug already used in other diseases, which could facilitate its use in bacterial infections.
22/04/2025 - Covid-19
A study led by the Hospital del Mar Research Institute, in collaboration with the Caldes de Montbui City Council, has validated the use of thermal waters to reduce some symptoms in people affected by long COVID. Balneotherapy helped improve pain and fatigue, with benefits that persisted after treatment ended. Improvements were also observed in sleep quality and anxiety, although these did not last over time. People with long COVID who underwent a one-month thermal water treatment program were twice as likely to improve their symptoms compared to those who did not receive the treatment.
Més informació "Balneotherapy Improves Various Symptoms of Long COVID"
13/03/2025 - Press release
A study led by the Hospital del Mar Research Institute has established the importance of immunoglobulin A, an antibody that is part of the immune system, in generating a response to pneumonia vaccines. Researchers have found that the absence of this antibody leads to an overgrowth of gut microbiota, triggering an excessive and sustained immune system response, which ultimately becomes exhausted and fails to respond effectively to vaccines. The study, published in Science Advances, opens the door to exploring the possibility of early immunoglobulin therapy administration to prevent this process and reduce the risk of potentially dangerous infections, even in at-risk individuals without a diagnosed immunodeficiency.
Més informació "The relationship between gut microbiota, immunoglobulin A, and vaccine efficacy"
24/02/25 - General information
Hospital del Mar and its research institute are part of this project, which aims to develop nanophotonic sensors for the diagnosis and clinical management of bacterial infections at the point of care. On February 14, Hospital del Mar hosted the fourth follow-up meeting of the PHITBAC project. This initiative is driven by a consortium with public and private participation to develop rapid tests for the swift detection of bacteria, their antibiotic resistance, and antibiotic levels in the blood, all based on nanophotonics. Rapid diagnosis of microorganisms that cause severe infections remains an unresolved challenge in infectious disease management, and immediate bedside monitoring of antibiotic levels in severe infections is an unmet need.
21/02/2025 - General information
Dr. Joaquim Gea, Emeritus Head of the Pulmonology Department and researcher at the Hospital del Mar Research Institute, has been appointed as the coordinator of two special issues of the journals Cells and International Journal of Molecular Science. His role will involve selecting both the topics and the authors of the articles to be featured in these issues.
04/12/2024 - General information
She will hold the position for two years and will be responsible for reviewing and supervising the evaluation processes of each call within her field at the agency. Dr. Esther Barreiro, an associate physician in the Pulmonology Service at Hospital del Mar and a researcher at its research institute, has been appointed as the coordinator in the field of medical and health sciences at the Agency for the Management of University and Research Grants (AGAUR).
14/11/2024 - General information
This is a body created to advise the government in this field. Dr. Albert Goday, emeritus section head of the Endocrinology and Nutrition Department at Hospital del Mar, researcher at its research institute, and associate professor of Medicine at UPF, has been appointed president of the Advisory Council on Diabetes in Catalonia. This council's role is to provide guidance to the government on diabetes, and it includes endocrinologists, family doctors, nurses, as well as patients and representatives from patient associations.
02/10/2024 - Press release
· Chronic obstructive pulmonary disease (COPD) patients who die had, years earlier, a higher presence of about thirty proteins in their blood related to inflammation and coagulation. · Detecting these proteins allows for a very accurate prediction of future mortality risk in patients with stable COPD, according to a multicenter pilot study led by Hospital del Mar, recently published in the journal Cells. · Researchers used various models to predict mortality risk through an AI-assisted program developed by the Biomedical Informatics Research Group at Pompeu Fabra University (UPF) and the Hospital del Mar Research Institute, one of which reached a precision level of 95%.
Més informació "Blood markers identified to predict long-term mortality in stable COPD patients"
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
